Lobbying client · LD-2 disclosures
Acceleron Pharma, Inc
Massachusetts
6 filings from 2 registrants · 2021–2022 · latest filed Apr 21, 2022
Reported on its behalf
$150K
every LD-2 on file
Its own filed spend
$60K
lobbying for itself
Fees to outside firms
$90K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
6 filings
$150K on those filings
Medicare/Medicaid
MMM
3 filings
$90K on those filings
Taxation/Internal Revenue Code
TAX
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Amy Jensen Splitoak Strategies LLCCovered position: Special Assistant to the President for Legislative Affairs (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999)4 filingsthrough 2022
- Greg Chesmore Acceleron Pharma Inc4 filingsthrough 2021
- Sarah Kuehl Egge Splitoak Strategies LLCCovered position: Legislative Assistant, Sen. Bob Kerrey (1998-2000); Senior Budget Analyst, Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)1 filingthrough 2021
Covered positions · 2 of 3 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: acceleron-pharma-inc.